{"product_id":"cep55-antibody-sc-f3504","title":"CEP55 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eCEP55 (Centrosomal Protein 55) is a multifunctional, centrosome-associated, α-helical coiled-coil protein that plays a pivotal role in cytokinesis, specifically facilitating the final abscission step by recruiting and interacting with crucial proteins such as ALIX and TSG101 at the midbody during late mitosis. It localizes to the mitotic spindle and subsequently to the spindle midzone and midbody, ensuring the proper separation of daughter cells and the completion of cell division. Depending on the literature source, CEP55 may also be discussed as Centrosomal protein of 55 kDa; Cep55; Up-regulated in colon cancer 6; CEP55; C10orf3.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm and cytoskeleton, which can matter when signal is compared across treatments or changing cell states. Following CEP55 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eCEP55 is commonly interpreted in the context of cancer, cell cycle, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and cytoskeleton, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm and cytoskeleton across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003ecell-cycle linked differences in abundance, timing, or compartmental enrichment\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CEP55. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CEP55 reflect biology rather than handling. When interpreting CEP55, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep CEP55 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57578027647321,"sku":"F3504-20UL","price":139.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57578027680089,"sku":"F3504-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57578027712857,"sku":"F3504-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F3504-wb.gif?v=1773601266","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/cep55-antibody-sc-f3504","provider":"Absource Diagnostics","version":"1.0","type":"link"}